Click for best price
CAR TCell Therapy Agents Market Size, Share 2023
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report aims to provide a comprehensive presentation of the global market for CAR T-Cell Therapy Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell Therapy Agents. This report contains market size and forecasts of CAR T-Cell Therapy Agents in global, including the following market information:
Global CAR T-Cell Therapy Agents Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CAR T-Cell Therapy Agents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19-targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR T-Cell Therapy Agents include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), CARsgen Therapeutics and Autolus Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
we surveyed the CAR T-Cell Therapy Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR T-Cell Therapy Agents Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CAR T-Cell Therapy Agents Market Segment Percentages, by Type, 2022 (%)
CD19-targeted
BCMA-targeted
Global CAR T-Cell Therapy Agents Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CAR T-Cell Therapy Agents Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global CAR T-Cell Therapy Agents Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CAR T-Cell Therapy Agents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-Cell Therapy Agents revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR T-Cell Therapy Agents revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR T-Cell Therapy Agents, market overview.
Chapter 2: Global CAR T-Cell Therapy Agents market size in revenue.
Chapter 3: Detailed analysis of CAR T-Cell Therapy Agents company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR T-Cell Therapy Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
CAR T-Cell Therapy Agents Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell Therapy Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-Cell Therapy Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Therapy Agents Overall Market Size
2.1 Global CAR T-Cell Therapy Agents Market Size: 2022 VS 2029
2.2 Global CAR T-Cell Therapy Agents Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell Therapy Agents Players in Global Market
3.2 Top Global CAR T-Cell Therapy Agents Companies Ranked by Revenue
3.3 Global CAR T-Cell Therapy Agents Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell Therapy Agents Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-Cell Therapy Agents Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Therapy Agents Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell Therapy Agents Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Agents Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR T-Cell Therapy Agents Market Size Markets, 2022 & 2029
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 By Type - Global CAR T-Cell Therapy Agents Revenue & Forecasts
4.2.1 By Type - Global CAR T-Cell Therapy Agents Revenue, 2018-2023
4.2.2 By Type - Global CAR T-Cell Therapy Agents Revenue, 2024-2029
4.2.3 By Type - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-Cell Therapy Agents Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global CAR T-Cell Therapy Agents Revenue & Forecasts
5.2.1 By Application - Global CAR T-Cell Therapy Agents Revenue, 2018-2023
5.2.2 By Application - Global CAR T-Cell Therapy Agents Revenue, 2024-2029
5.2.3 By Application - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global CAR T-Cell Therapy Agents Market Size, 2022 & 2029
6.2 By Region - Global CAR T-Cell Therapy Agents Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell Therapy Agents Revenue, 2018-2023
6.2.2 By Region - Global CAR T-Cell Therapy Agents Revenue, 2024-2029
6.2.3 By Region - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America CAR T-Cell Therapy Agents Revenue, 2018-2029
6.3.2 US CAR T-Cell Therapy Agents Market Size, 2018-2029
6.3.3 Canada CAR T-Cell Therapy Agents Market Size, 2018-2029
6.3.4 Mexico CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell Therapy Agents Revenue, 2018-2029
6.4.2 Germany CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4.3 France CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4.4 U.K. CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4.5 Italy CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4.6 Russia CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4.7 Nordic Countries CAR T-Cell Therapy Agents Market Size, 2018-2029
6.4.8 Benelux CAR T-Cell Therapy Agents Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell Therapy Agents Revenue, 2018-2029
6.5.2 China CAR T-Cell Therapy Agents Market Size, 2018-2029
6.5.3 Japan CAR T-Cell Therapy Agents Market Size, 2018-2029
6.5.4 South Korea CAR T-Cell Therapy Agents Market Size, 2018-2029
6.5.5 Southeast Asia CAR T-Cell Therapy Agents Market Size, 2018-2029
6.5.6 India CAR T-Cell Therapy Agents Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America CAR T-Cell Therapy Agents Revenue, 2018-2029
6.6.2 Brazil CAR T-Cell Therapy Agents Market Size, 2018-2029
6.6.3 Argentina CAR T-Cell Therapy Agents Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell Therapy Agents Revenue, 2018-2029
6.7.2 Turkey CAR T-Cell Therapy Agents Market Size, 2018-2029
6.7.3 Israel CAR T-Cell Therapy Agents Market Size, 2018-2029
6.7.4 Saudi Arabia CAR T-Cell Therapy Agents Market Size, 2018-2029
6.7.5 UAE CAR T-Cell Therapy Agents Market Size, 2018-2029
7 CAR T-Cell Therapy Agents Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-Cell Therapy Agents Major Product Offerings
7.1.4 Novartis CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-Cell Therapy Agents Major Product Offerings
7.2.4 Gilead Sciences CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-Cell Therapy Agents Major Product Offerings
7.4.4 J & J CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-Cell Therapy Agents Major Product Offerings
7.5.4 JW Therapeutics CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-Cell Therapy Agents Major Product Offerings
7.6.4 FOSUNKite CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics (Pipeline)
7.7.1 CARsgen Therapeutics (Pipeline) Company Summary
7.7.2 CARsgen Therapeutics (Pipeline) Business Overview
7.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Major Product Offerings
7.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.7.5 CARsgen Therapeutics (Pipeline) Key News & Latest Developments
7.8 CARsgen Therapeutics
7.8.1 CARsgen Therapeutics Company Summary
7.8.2 CARsgen Therapeutics Business Overview
7.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Major Product Offerings
7.8.4 CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.8.5 CARsgen Therapeutics Key News & Latest Developments
7.9 Autolus Therapeutics
7.9.1 Autolus Therapeutics Company Summary
7.9.2 Autolus Therapeutics Business Overview
7.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Major Product Offerings
7.9.4 Autolus Therapeutics CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.9.5 Autolus Therapeutics Key News & Latest Developments
7.10 Sorrento Therapeutics
7.10.1 Sorrento Therapeutics Company Summary
7.10.2 Sorrento Therapeutics Business Overview
7.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Major Product Offerings
7.10.4 Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.10.5 Sorrento Therapeutics Key News & Latest Developments
7.11 Mustang Bio
7.11.1 Mustang Bio Company Summary
7.11.2 Mustang Bio Business Overview
7.11.3 Mustang Bio CAR T-Cell Therapy Agents Major Product Offerings
7.11.4 Mustang Bio CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.11.5 Mustang Bio Key News & Latest Developments
7.12 Bluebird Bio
7.12.1 Bluebird Bio Company Summary
7.12.2 Bluebird Bio Business Overview
7.12.3 Bluebird Bio CAR T-Cell Therapy Agents Major Product Offerings
7.12.4 Bluebird Bio CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.12.5 Bluebird Bio Key News & Latest Developments
7.13 Cellectis
7.13.1 Cellectis Company Summary
7.13.2 Cellectis Business Overview
7.13.3 Cellectis CAR T-Cell Therapy Agents Major Product Offerings
7.13.4 Cellectis CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.13.5 Cellectis Key News & Latest Developments
7.14 Allogene Therapeutics
7.14.1 Allogene Therapeutics Company Summary
7.14.2 Allogene Therapeutics Business Overview
7.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Major Product Offerings
7.14.4 Allogene Therapeutics CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.14.5 Allogene Therapeutics Key News & Latest Developments
7.15 Celyad
7.15.1 Celyad Company Summary
7.15.2 Celyad Business Overview
7.15.3 Celyad CAR T-Cell Therapy Agents Major Product Offerings
7.15.4 Celyad CAR T-Cell Therapy Agents Revenue in Global Market (2018-2023)
7.15.5 Celyad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR T-Cell Therapy Agents Market Opportunities & Trends in Global Market
Table 2. CAR T-Cell Therapy Agents Market Drivers in Global Market
Table 3. CAR T-Cell Therapy Agents Market Restraints in Global Market
Table 4. Key Players of CAR T-Cell Therapy Agents in Global Market
Table 5. Top CAR T-Cell Therapy Agents Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR T-Cell Therapy Agents Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR T-Cell Therapy Agents Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR T-Cell Therapy Agents Product Type
Table 9. List of Global Tier 1 CAR T-Cell Therapy Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CAR T-Cell Therapy Agents Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR T-Cell Therapy Agents Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CAR T-Cell Therapy Agents Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR T-Cell Therapy Agents Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CAR T-Cell Therapy Agents Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR T-Cell Therapy Agents Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis CAR T-Cell Therapy Agents Product Offerings
Table 32. Novartis CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR T-Cell Therapy Agents Product Offerings
Table 36. Gilead Sciences CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product Offerings
Table 40. Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J CAR T-Cell Therapy Agents Product Offerings
Table 44. J & J CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics CAR T-Cell Therapy Agents Product Offerings
Table 48. JW Therapeutics CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite CAR T-Cell Therapy Agents Product Offerings
Table 52. FOSUNKite CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 53. FOSUNKite Key News & Latest Developments
Table 54. CARsgen Therapeutics (Pipeline) Company Summary
Table 55. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product Offerings
Table 56. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 57. CARsgen Therapeutics (Pipeline) Key News & Latest Developments
Table 58. CARsgen Therapeutics Company Summary
Table 59. CARsgen Therapeutics CAR T-Cell Therapy Agents Product Offerings
Table 60. CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 61. CARsgen Therapeutics Key News & Latest Developments
Table 62. Autolus Therapeutics Company Summary
Table 63. Autolus Therapeutics CAR T-Cell Therapy Agents Product Offerings
Table 64. Autolus Therapeutics CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 65. Autolus Therapeutics Key News & Latest Developments
Table 66. Sorrento Therapeutics Company Summary
Table 67. Sorrento Therapeutics CAR T-Cell Therapy Agents Product Offerings
Table 68. Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 69. Sorrento Therapeutics Key News & Latest Developments
Table 70. Mustang Bio Company Summary
Table 71. Mustang Bio CAR T-Cell Therapy Agents Product Offerings
Table 72. Mustang Bio CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 73. Mustang Bio Key News & Latest Developments
Table 74. Bluebird Bio Company Summary
Table 75. Bluebird Bio CAR T-Cell Therapy Agents Product Offerings
Table 76. Bluebird Bio CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 77. Bluebird Bio Key News & Latest Developments
Table 78. Cellectis Company Summary
Table 79. Cellectis CAR T-Cell Therapy Agents Product Offerings
Table 80. Cellectis CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 81. Cellectis Key News & Latest Developments
Table 82. Allogene Therapeutics Company Summary
Table 83. Allogene Therapeutics CAR T-Cell Therapy Agents Product Offerings
Table 84. Allogene Therapeutics CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 85. Allogene Therapeutics Key News & Latest Developments
Table 86. Celyad Company Summary
Table 87. Celyad CAR T-Cell Therapy Agents Product Offerings
Table 88. Celyad CAR T-Cell Therapy Agents Revenue (US$, Mn) & (2018-2023)
Table 89. Celyad Key News & Latest Developments
List of Figures
Figure 1. CAR T-Cell Therapy Agents Segment by Type in 2022
Figure 2. CAR T-Cell Therapy Agents Segment by Application in 2022
Figure 3. Global CAR T-Cell Therapy Agents Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR T-Cell Therapy Agents Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CAR T-Cell Therapy Agents Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell Therapy Agents Revenue in 2022
Figure 8. By Type - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 9. By Application - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 10. By Type - Global CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 12. By Application - Global CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 14. By Region - Global CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 15. By Country - North America CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 16. US CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 20. Germany CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 21. France CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 28. China CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 32. India CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 34. Brazil CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CAR T-Cell Therapy Agents Revenue Market Share, 2018-2029
Figure 37. Turkey CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CAR T-Cell Therapy Agents Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J & J CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. JW Therapeutics CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FOSUNKite CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. CARsgen Therapeutics CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Autolus Therapeutics CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sorrento Therapeutics CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mustang Bio CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bluebird Bio CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cellectis CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Allogene Therapeutics CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Celyad CAR T-Cell Therapy Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
